SOX4 and nasopharyngeal carcinoma: Furthermore, RNA-seq performed on 53 diagnostic NPC biopsy samples revealed that patients with higher than median SOX4 transcript levels experienced a lower 10-year distant relapse-free survival (DRFS) compared to those with lower levels (p = 0.063) (Fig. 2f).